Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07337538

Evaluation of Two Mini-implant Diameters in the Infra-zygomatic Crest Region.

The goal of this clinical trials is to compare two diameters, 1.6 and 2 mm, of mini implants both are 12 mm length placed in the infrazygomatic crest region. The main questions it aims to answer are:

which diameter is more suitable for IZC region 1.6 or 2mm in terms of primary stability, secondary stability, pain perception and failure rate.

20 participant will receive 40 mini implant bilaterally (20 in one side of 1.6mm, the other side 20 of 2mm).

participants will be asked to record visual analog scale (VAS) for 3 nights monitored monthly by the investigator.

Recruiting

Interested in participating?

Request Info

Key information

Age range

15 year–38 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Baghdad university, Baghdad, Baghdad Governorate, Iraq

Loading trial locations.

About this study

Using 1.6x12mm and 2x12mm of mini implants in the IZC area and measuring primary stability, secondary stability, failure rate and pain perception.

The primary stability will be measured immediately after insertion using Easycheck device (Dentium, South Korea).

The secondary stability will be measured two months after insertion using the same device.

Failure is considered when the mini implant become loose, peri-implant inflammation or fallen after insertion, it will be checked monthly for six months.

pain perception will be recorded by patients using visual analog scale (VAS) score sheet 24 , 48, 72 hour after insertion.

Null hypothesis There is no significant difference between 1.6 and 2mm IZC mini implant diameters in terms of primary stability, secondary stability, failure rate and pain perception.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals aged between 15 and 38 years.
  • Patients currently undergoing orthodontic treatment with fixed appliances who require mini-implant placement in the upper buccal posterior region (IZC) for full-arch distalization or en-masse retraction.
  • Patients willing and able to adhere to the study protocol.
  • Recommended for the use of bilateral mini-implants.

Exclusion criteria

  • Syndromic conditions, facial trauma, or previous bone-related surgery.

Treatment and study plan

insersion of two diameters of mini implant.

Device

insertion of the two diameters in the infrazygomatic crest region (IZC) bilaterally (one for each side) then check difference in primary stability, secondary stability, pain perception and failure rate.

Primary outcomes

  1. primary stability

    Time frame: immediately after insertion

    primary stability measurement using easy check device (Dentium, south Korea) giving range of (1 - 100).

  2. secondary stability

    Time frame: two month after insertion.

    secondary stability measurement using easy check device (Dentium, south Korea) giving range of (1 - 100).

Secondary outcomes

  1. pain perception

    Time frame: after insertion 24 hour, 48 hour, 72 hour.

    using Visual Analogue Score (VAS) [1-10] higher score means higher pain.

  2. Failure rate

    Time frame: monthly for six months after insertion.

    Failure is considered when the mini implant become loose, peri-implant inflammation or fallen after insertion.

Study contacts

Contact information is provided by the study sponsor or research team.

Ali J. Al Ameri, BDS.

CONTACT

[email protected]

+9647775039229

Mehdi A. Alrubayee, PHD.

CONTACT

[email protected]

+9647703909151

Sponsors and collaborators

Lead sponsor

University of Baghdad

Other

Registry information

Official study title

Evaluation of Two Mini-implant Diameters in the Infra-zygomatic Crest Region (Split-mouth Randomized Clinical Trial)

Acronym: TADs

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jan 13, 2026
Registry last updated
Jan 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.